The short version
- Why people research itAppetite suppression and fat loss via triple monoamine reuptake inhibition.
- What the evidence isReached phase 2 in humans with striking results — around 10% weight loss at 24 weeks, roughly double what any approved drug achieved at the time.
- What to watchPalpitations or chest pain.
How Tesofensine works
Triple monoamine reuptake inhibitor (noradrenaline, dopamine, serotonin) — cuts appetite centrally.
Tesofensine blocks three monoamine transporters at once, and the order of potency is the whole pharmacology. It inhibits the noradrenaline transporter, the dopamine transporter and the serotonin transporter — a triple reuptake inhibitor.
Where the appetite effect comes from, anatomically. Noradrenaline and dopamine signaling in the hypothalamus — particularly at the arcuate and paraventricular nuclei — is part of the circuit that terminates a meal; serotonin acting at 5-HT2C receptors on POMC neurons does the same. Blocking reuptake of all three raises tone in that circuit.
- Oral
Research on Tesofensine7 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Human trials (Phase 2).
Human clinical evidence
Reached phase 2 in humans with striking results — around 10% weight loss at 24 weeks, roughly double what any approved drug achieved at the time. It had originally been developed for Parkinson's and Alzheimer's, where it failed.
Development for obesity stalled over cardiovascular signals — in a regulatory climate shaped by sibutramine's withdrawal for exactly that reason. It was later approved in Mexico as Obesidex.
Correlative data
Research-market use for fat loss. Reported experience is strong appetite suppression with the expected stimulant burden: insomnia, dry mouth, raised heart rate.
Sibutramine is the cautionary precedent. It was approved, widely used, and withdrawn in 2010 after SCOUT showed increased cardiovascular events — a triple-reuptake mechanism producing exactly the harm this drug's phase 2 vital signs hinted at.
How the mechanism reads
A triple monoamine reuptake inhibitor — blocking reuptake of noradrenaline, dopamine and serotonin simultaneously, which increases satiety signaling and energy expenditure.
MechanisticHitting all three is why it works and why it is risky. Noradrenaline drives the appetite suppression and the blood pressure; dopamine drives the reward-related reduction in eating and the abuse potential; serotonin adds satiety and the interaction risk with SSRIs.
MechanisticThe cardiovascular effect is not incidental to the mechanism — it is the noradrenergic arm doing exactly what noradrenaline does.
Mechanistic
Sources
- Astrup A, et al. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. The Lancet 2008 · PMID 18950853
- Huynh K, et al. Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity. European Journal of Endocrinology 2022 · PMID 35294397
- Abdi Beshir S, et al. A narrative review of approved and emerging anti-obesity medications. Saudi Pharmaceutical Journal 2023 · PMID 37712012
Tesofensine safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- High blood pressure, arrhythmia or heart disease: noradrenaline reuptake blockade raises pulse and pressure.
- MAOIs, SSRIs or other stimulants: serotonin and noradrenaline load stack.
- Anxiety, bipolar disorder or a history of psychosis.
- Seizure history: triple monoamine reuptake blockade can lower the seizure threshold.
- Pregnancy: central appetite suppression and noradrenaline load have no fetal data.
What’s expected
- Marked appetite loss from monoamine reuptake blockade in the brain.
- Higher pulse and blood pressure.
- Dry mouth, insomnia and constipation.
- Lifted mood or irritability.
Watch for
- Palpitations or chest pain.
- Agitation, sweating, fever and tremor while using Tesofensine.
- Blood pressure that stays high.
- Worsening mood or suicidal thoughts.
Labs that tell you it’s working
- Comprehensive Metabolic Panel (CMP)
- Lipid Panel
- TSH (Thyroid-Stimulating Hormone)
- Cortisol
Tesofensine blocks noradrenaline, dopamine and serotonin reuptake, so cardiovascular, sleep and mood effects follow; Phase 2 trials showed weight loss. PMID 18950853
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Tesofensine FAQ4 common questions
- Is Tesofensine approved for human use?
- No. Tesofensine is a research compound.
- What is Tesofensine researched for?
- Appetite suppression and fat loss via triple monoamine reuptake inhibition.
- Which labs show whether it's doing anything?
- Comprehensive Metabolic Panel; Lipid Panel; TSH; Cortisol: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Tesofensine: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.




